Novo Nordisk announced Monday that in two closely watched studies, an oral version of semaglutide — the active ingredient in weight loss drugs — failed to help slow the progression of Alzheimer’s.

Instead of struggling with weekly injections, patients may soon be able to swallow a daily pill to lose weight. Both the ...

In an era where the conversation around weight loss is often dominated by the latest injectable medications, many might wonder if the more established tools, like bariatric surgery, still hold a place ...